Chickenpox cases down 85 percent with second vaccine implemented

Written by Emily Lunardo
Published on

Chicken Pox on a toddlerU.S. health officials have noted a decline in chickenpox cases since the recommendation for a second vaccine was implemented in 2006. There has been an 85 percent decline in chickenpox cases since 2005. The largest decline was among five- to 14-year-olds, which is typical age group to receive the second vaccination.

Chickenpox was quite common prior to vaccination, with four million children contracting it annually back in the 1990s. The CDC suggests that vaccinations have prevented 3.5 million chickenpox cases, along with hospitalizations and deaths associated with chickenpox.

The chickenpox cannot be prevented 100 percent, but the disease is often milder and short-lived in those who have been vaccinated.
Corresponding author Adriana Lopez and colleagues wrote, “Further reduction in the number of varicella cases will provide states with increased opportunities for enhancing varicella surveillance and improving completeness of reporting to monitor impact of the vaccination program.”

The single-dose vaccine was introduced in 1996, resulting in a 90 percent decline in cases. Ten years later, the second vaccine was recommended , further reducing the numbers of chickenpox cases.

In 2014, only 40 states reported cases of chickenpox.

Sources:
https://consumer.healthday.com/infectious-disease-information-21/chickenpox-news-123/continued-success-with-2-doses-of-chickenpox-vaccine-714518.html


Advertisement

On any matter relating to your health or well-being, please check with an appropriate health professional. No statement herein is to be construed as a diagnosis, treatment, preventative, or cure for any disease, disorder or abnormal physical state. The statements herein have not been evaluated by the Foods and Drugs Administration or Health Canada. Dr. Marchione and the doctors on the Bel Marra Health Editorial Team are compensated by Bel Marra Health for their work in creating content, consulting along with formulating and endorsing products.

Exit mobile version